WallStreetZenWallStreetZen

NASDAQ: HYPR
Hyperfine Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for HYPR

Based on 2 analysts offering 12 month price targets for Hyperfine Inc

Min Forecast
$2.00+15.61%
Avg Forecast
$2.25+30.06%
Max Forecast
$2.50+44.51%

Should I buy or sell HYPR stock?

Based on 2 analysts offering ratings for Hyperfine Inc.

Strong Buy
Strong Buy
2 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although HYPR's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates HYPR as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their HYPR stock forecasts and price targets.

HYPR stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-04-29
lockedlocked$00.00+00.00%2026-03-19

1 of 1

Forecast return on equity

Is HYPR forecast to generate an efficient return?

Company
-82.85%
Industry
18.7%
Market
150.4%
HYPR's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is HYPR forecast to generate an efficient return on assets?

Company
-61.47%
Industry
12.56%
HYPR is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

HYPR earnings per share forecast

What is HYPR's earnings per share in the next 2 years based on estimates from 5 analysts?

Avg 1 year Forecast
-$0.35
Avg 2 year Forecast
-$0.34

HYPR revenue forecast

What is HYPR's revenue in the next 2 years based on estimates from 5 analysts?

Avg 1 year Forecast
$20.4M+50.64%
Avg 2 year Forecast
$26.8M+97.41%
HYPR's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

HYPR revenue growth forecast

How is HYPR forecast to perform vs Medical Devices companies and vs the US market?

Company
33.18%
Industry
9.02%
Market
16.85%
HYPR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
HYPR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

HYPR vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
HYPR$1.73$2.25+30.06%Strong Buy
QTRX$3.29$4.00+21.58%Hold
CVRX$7.07$10.00+41.44%Strong Buy
LUCD$1.08$4.83+347.50%Strong Buy
INGN$7.11$12.00+68.78%Strong Buy
View Top Medical Device Stocks

Hyperfine Stock Forecast FAQ

Is Hyperfine Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: HYPR) stock is to Strong Buy HYPR stock.

Out of 2 analysts, 2 (100%) are recommending HYPR as a Strong Buy, 0 (0%) are recommending HYPR as a Buy, 0 (0%) are recommending HYPR as a Hold, 0 (0%) are recommending HYPR as a Sell, and 0 (0%) are recommending HYPR as a Strong Sell.

If you're new to stock investing, here's how to buy Hyperfine stock.

What is HYPR's earnings growth forecast for 2026-2027?

(NASDAQ: HYPR) Hyperfine's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 31%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 67.68%.

Hyperfine's earnings in 2026 is -$35,574,000.On average, 5 Wall Street analysts forecast HYPR's earnings for 2026 to be -$34,471,318, with the lowest HYPR earnings forecast at -$33,599,495, and the highest HYPR earnings forecast at -$34,970,902.

In 2027, HYPR is forecast to generate -$32,972,565 in earnings, with the lowest earnings forecast at -$31,679,523 and the highest earnings forecast at -$33,942,347.

What is HYPR's revenue growth forecast for 2026-2027?

(NASDAQ: HYPR) Hyperfine's forecast annual revenue growth rate of 33.18% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 9.02%, and it is also forecast to beat the US market's average forecast revenue growth rate of 16.85%.

Hyperfine's revenue in 2026 is $13,563,000.On average, 5 Wall Street analysts forecast HYPR's revenue for 2026 to be $2,001,373,973, with the lowest HYPR revenue forecast at $1,919,971,116, and the highest HYPR revenue forecast at $2,066,417,892.

In 2027, HYPR is forecast to generate $2,622,817,685 in revenue, with the lowest revenue forecast at $2,495,962,451 and the highest revenue forecast at $2,725,673,281.

What is HYPR's forecast return on assets (ROA) for 2026-2028?

(NASDAQ: HYPR) forecast ROA is -61.47%, which is lower than the forecast US Medical Devices industry average of 12.56%.

What is HYPR's Price Target?

According to 2 Wall Street analysts that have issued a 1 year HYPR price target, the average HYPR price target is $2.25, with the highest HYPR stock price forecast at $2.50 and the lowest HYPR stock price forecast at $2.00.

On average, Wall Street analysts predict that Hyperfine's share price could reach $2.25 by Apr 29, 2027. The average Hyperfine stock price prediction forecasts a potential upside of 30.06% from the current HYPR share price of $1.73.

What is HYPR's Earnings Per Share (EPS) forecast for 2026-2027?

(NASDAQ: HYPR) Hyperfine's current Earnings Per Share (EPS) is -$0.43. On average, analysts forecast that HYPR's EPS will be -$0.35 for 2026, with the lowest EPS forecast at -$0.34, and the highest EPS forecast at -$0.36. In 2027, HYPR's EPS is forecast to hit -$0.34 (min: -$0.32, max: -$0.35).

What is HYPR's forecast return on equity (ROE) for 2026-2028?

(NASDAQ: HYPR) forecast ROE is -82.85%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.